News searcher
ROVI achieves second place in a worldwide sustainability rating
Laboratorios Farmacéuticos ROVI, S.A. achieved the second best ESG rating out of 432 companies assessed in the...
1 min
09 Aug, 2021
ROVI achieves an increase of 52% in operating income and 75% in EBITDA
Summary of financial results for the first half of 2021
6 min
28 Jul, 2021
First half 2021 results presentation
Operating income, growth figures, profitability and how our products have behaved.
0 min
28 Jul, 2021
ROVI holds its 2021 General Shareholders Meeting
ROVI holds its 2021 General Shareholders Meeting
ROVI increases operating income by 10% and net profit by 55% in 2020
6 min
17 Jun, 2021
The President of the Spanish government, Pedro Sánchez, makes an institutional visit to...
Institutional visit of the President of the Government of Spain
2 min
14 May, 2021
ROVI achieves an increase of 29% in operating income and 74% in EBITDA
ROVI achieves an increase of 29% in operating income and 74% in EBITDA
ROVI reports first quarter 2021 financial results
6 min
13 May, 2021
First quarter 2021 results presentation
Operating income, growth figures, profitability and how our products have behaved.
0 min
13 May, 2021
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
ROVI invests in two new production lines at ROVI's facilities in San Sebastián de los Reyes (Madrid). These lines...
2 min
29 Apr, 2021
ROVI participates in the manufacture of the active substance of Moderna’s COVID-19 vaccine
Investment in a new production line at ROVI's Granada facility, which will lead to greater vertical integration in...
2 min
12 Apr, 2021